Want to see IN:BLUEJET full AI Analyst Report?
Blue Jet Healthcare Limited (BLUEJET) Ratios
Blue Jet Healthcare Limited Ratios
IN:BLUEJET's free cash flow for Q1 2027 was $0.00. For the 2027 fiscal year, IN:BLUEJET's free cash flow was increased by $0.00 and operating cash flow was $0.00. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 4.21 | 3.93 | 3.43 | 3.82 | 3.14 |
| Quick Ratio | 3.38 | 2.90 | 2.80 | 3.08 | 2.53 |
| Cash Ratio | 0.65 | 0.47 | 0.20 | 0.38 | 0.43 |
| Solvency Ratio | 0.97 | 1.14 | 0.90 | 1.03 | 1.06 |
| Operating Cash Flow Ratio | 1.49 | 0.18 | 1.17 | 0.81 | 0.84 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 41.74 | 26.52 |
| Net Current Asset Value | $ 6.76B | $ 7.22B | $ 4.92B | $ 4.84B | $ 3.56B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.03 | 0.01 | 0.00 | 0.01 | 0.03 |
| Debt-to-Equity Ratio | 0.03 | 0.02 | 0.00 | 0.01 | 0.04 |
| Debt-to-Capital Ratio | 0.03 | 0.02 | 0.00 | 0.01 | 0.04 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.21 | 1.25 | 1.25 | 1.26 | 1.37 |
| Debt Service Coverage Ratio | 33.56 | 3296.84 | 1192.57 | 39.25 | 23.47 |
| Interest Coverage Ratio | 43.29 | 3672.87 | 2094.55 | 144.49 | 67.40 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 2.79 | 1.16 | 0.10 | 0.47 | 1.51 |
| Net Debt to EBITDA | -0.36 | -0.24 | -0.16 | -0.24 | -0.20 |
| Profitability Margins | |||||
| Gross Profit Margin | 43.70% | 54.42% | 54.78% | 37.62% | 43.82% |
| EBIT Margin | 28.51% | 39.44% | 31.01% | 30.34% | 36.43% |
| EBITDA Margin | 31.05% | 41.16% | 34.96% | 33.83% | 39.70% |
| Operating Profit Margin | 28.51% | 34.95% | 47.47% | 27.33% | 32.87% |
| Pretax Profit Margin | 35.10% | 39.43% | 30.99% | 30.15% | 35.94% |
| Net Profit Margin | 26.16% | 29.63% | 23.05% | 22.27% | 26.83% |
| Continuous Operations Profit Margin | 26.16% | 29.63% | 23.05% | 22.27% | 26.83% |
| Net Income Per EBT | 74.53% | 75.15% | 74.40% | 73.88% | 74.66% |
| EBT Per EBIT | 123.11% | 112.82% | 65.27% | 110.31% | 109.35% |
| Return on Assets (ROA) | 15.10% | 21.53% | 15.47% | 18.56% | 25.46% |
| Return on Equity (ROE) | 18.22% | 26.93% | 19.37% | 23.48% | 34.82% |
| Return on Capital Employed (ROCE) | 19.11% | 30.99% | 39.54% | 28.53% | 41.28% |
| Return on Invested Capital (ROIC) | 14.19% | 23.22% | 29.37% | 20.92% | 30.28% |
| Return on Tangible Assets | 15.12% | 21.54% | 15.47% | 18.56% | 25.46% |
| Earnings Yield | 4.37% | 2.09% | 2.41% | 2.23% | 2.53% |
| Efficiency Ratios | |||||
| Receivables Turnover | 2.79 | 2.95 | 4.01 | 2.98 | 2.94 |
| Payables Turnover | 9.37 | 5.28 | 10.60 | 8.33 | 6.72 |
| Inventory Turnover | 2.85 | 1.78 | 2.47 | 3.47 | 3.60 |
| Fixed Asset Turnover | 1.54 | 2.65 | 2.23 | 3.71 | 4.18 |
| Asset Turnover | 0.58 | 0.73 | 0.67 | 0.83 | 0.95 |
| Working Capital Turnover Ratio | 1.28 | 1.65 | 1.43 | 1.66 | 2.26 |
| Cash Conversion Cycle | 219.92 | 259.57 | 204.03 | 183.92 | 171.20 |
| Days of Sales Outstanding | 130.63 | 123.87 | 90.92 | 122.55 | 124.02 |
| Days of Inventory Outstanding | 128.24 | 204.82 | 147.54 | 105.17 | 101.47 |
| Days of Payables Outstanding | 38.95 | 69.11 | 34.43 | 43.80 | 54.29 |
| Operating Cycle | 258.87 | 328.68 | 238.46 | 227.72 | 225.49 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 19.49 | 2.64 | 13.91 | 8.16 | 8.44 |
| Free Cash Flow Per Share | 0.00 | -1.97 | 3.86 | 4.74 | 6.96 |
| Dividend Paid and CapEx Coverage Ratio | 0.94 | 0.47 | 1.38 | 2.39 | 6.39 |
| Capital Expenditure Coverage Ratio | 1.00 | 0.57 | 1.38 | 2.39 | 6.39 |
| Operating Cash Flow Coverage Ratio | 8.01 | 2.29 | 149.57 | 20.72 | 6.41 |
| Operating Cash Flow to Sales Ratio | 0.36 | 0.04 | 0.34 | 0.20 | 0.22 |
| Free Cash Flow Yield | 0.00% | -0.23% | 0.99% | 1.15% | 1.68% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 22.90 | 47.79 | 41.46 | 44.81 | 39.49 |
| Price-to-Sales (P/S) Ratio | 5.99 | 14.16 | 9.56 | 9.98 | 10.60 |
| Price-to-Book (P/B) Ratio | 4.17 | 12.87 | 8.03 | 10.52 | 13.75 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 0.00 | -427.53 | 101.40 | 87.16 | 59.39 |
| Price-to-Operating Cash Flow Ratio | 16.79 | 318.70 | 28.14 | 50.66 | 48.98 |
| Price-to-Earnings Growth (PEG) Ratio | -1.22 | 0.55 | 18.22 | -3.78 | 1.27 |
| Enterprise Value Multiple | 18.93 | 34.16 | 27.18 | 29.26 | 26.49 |
| Enterprise Value | 55.68B | 144.85B | 67.50B | 71.12B | 71.19B |
| EV to EBITDA | 18.93 | 34.16 | 27.18 | 29.26 | 26.49 |
| EV to Sales | 5.88 | 14.06 | 9.50 | 9.90 | 10.52 |
| EV to Free Cash Flow | 0.00 | -424.60 | 100.81 | 86.44 | 58.95 |
| EV to Operating Cash Flow | 16.47 | 316.52 | 27.98 | 50.25 | 48.62 |
| Tangible Book Value Per Share | 78.29 | 65.28 | 48.71 | 39.28 | 30.07 |
| Shareholders’ Equity Per Share | 78.42 | 65.31 | 48.73 | 39.29 | 30.07 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.25 | 0.25 | 0.26 | 0.26 | 0.25 |
| Revenue Per Share | 54.63 | 59.36 | 40.95 | 41.42 | 39.02 |
| Net Income Per Share | 14.29 | 17.59 | 9.44 | 9.23 | 10.47 |
| Tax Burden | 0.75 | 0.75 | 0.74 | 0.74 | 0.75 |
| Interest Burden | 1.23 | 1.00 | 1.00 | 0.99 | 0.99 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.15 | 0.06 | 0.01 | 0.01 | 0.01 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.36 | 0.15 | 1.47 | 0.88 | 0.81 |
Currency in INR
